Combo of oral and topical photoprotection with P leucotomos extract beneficial against actinic keratosis

Against the above background, Giovanni Pellacani, Dermatology Clinic, University La Sapienza, Rome, Italy, and colleagues sought to evaluate the effects of specific topical formulations and the potential additional protection offered by oral photoprotection in high-risk subjects.

The researchers described a prospective, multicentre, randomized controlled, open-label study with three arms to study the differences between [T], topical treatment; [Cnt], self-administered sun protection; [TO], topical + oral treatment; for actinic keratosis management in a cohort of patients of advanced age displaying severe actinic damage (SAD).

There was a common component in the treatments given to groups [T] and [TO], a botanical extract, Fernblock, with demonstrated photoprotective activity.

The study revealed the following findings:

• In total, 131 subjects were distributed randomly in the three groups, followed up clinically at three different time points, at the beginning of the study (t = 0) and after 6 and 12 months.
• Analysis of clinical data and examination using reflectance confocal microscopy (RCM) revealed that group [T] and [TO] displayed decreased clinical AK and field cancerization parameters, including the number of new lesions, and reduced the need for additional interventions in these patients.
• RCM revealed normalization of the keratinocyte layer.
• Improvements in AK and field cancerization parameters were most significant in the group [TO], suggesting that topical and oral photoprotection improves the clinical and anatomical outcome compared to control conditions.

The findings showed that specific topical and topical + oral treatment with Fernblock of subjects already treated for AK and cancerization field (therefore at risk of recurrence) improved the control of AK and prevented new occurrences.

'"Polypodium leucotomos extract use reduces the development of new actinic keratoses, specifically among those who use both topical and oral immune photoprotection," the researchers conclude.